- 112888-43-44(3H)-Quinazolinone,6-(bromomethyl)-2-methyl-
- 112888-76-3tert-Butyl 4-(2-propynylamino)benzoate
- 112-88-91-Octadecene
- 112889-02-8L-Glutamic acid,N-[[5-(methylamino)-2-thienyl]carbonyl]-, 1,5-diethyl ester
- 112-89-0Octadecane, 1-bromo-
- 112892-88-3Bicyclo[4.2.0]octa-1,3,5-triene-3-carboxaldehyde
- 112897-97-92-Propenoic acid,3-(3,4-difluorophenyl)-, (2E)-
- 112897-99-1Cytidine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]- (9CI)
- 112898-00-7D-Glutamine,N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-
- 112898-06-3L-Prolinamide,L-arginyl-N-(4-nitrophenyl)-, dihydrochloride (9CI)
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Raltitrexed |
EINECS | 652-997-2 |
| CAS No. | 112887-68-0 | Density | 1.49 g/cm3 |
| PSA | 180.93000 | LogP | 2.36810 |
| Solubility | N/A | Melting Point |
176-180 °C |
| Formula | C21H22N4O6S | Boiling Point | N/A |
| Molecular Weight | 458.495 | Flash Point | N/A |
| Transport Information | N/A | Appearance | yellow crystalline powder |
| Safety | 26-37/39 | Risk Codes | 36/38 |
| Molecular Structure |
|
Hazard Symbols |
 Xi
|
| Synonyms |
D1694;Tomudex (TN);L-Glutamic acid,N-[[5-[[(1,4-dihydro-2- methyl-4-oxo-6-quinazolinyl)methyl]methylamino]- 2-thienyl]carbonyl]-;ZD1694;Raltitrexed (JAN/USAN);D 1694;(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid;L-Glutamic acid, N-((5-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thienyl)carbonyl)-;Tomudex;ICI-D1694;ICI D1694;N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid;(S)-2-[(1-{5-[Methyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-thiophen-2-yl}-methanoyl)-amino]-pentanedioic acid;ZD 1694;D-1694; |
Article Data | 7 |
Raltitrexed Chemical Properties
Molecular Structure of Raltitrexed (CAS NO.112887-68-0):
IUPAC Name: (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid
Molecular formula:C21H22N4O6S
Molecular Weight: 458.489
ACD/LogP: -1.58
of Rule of 5 Violations: 1
ACD/LogD (pH 5.5): -4.62
ACD/LogD (pH 7.4): -6.32
ACD/BCF (pH 5.5): 1
ACD/BCF (pH 7.4): 1
ACD/KOC (pH 5.5): 1
ACD/KOC (pH 7.4): 1
H bond acceptors: 10
H bond donors: 4
Freely Rotating Bonds: 9
Polar Surface Area: 137.06Å2
Index of Refraction: 1.692
Molar Refractivity: 117.35 cm3
Molar Volume: 306.1 cm3
Surface Tension: 63 dyne/cm
Melting point: 176-180°C
Density: 1.49 g/cm3
Appearance: Yellow Crystalline Powder
Product Categories: Active Pharmaceutical Ingredients; Raltitrexed; Intermediates & Fine Chemicals; Pharmaceuticals
Raltitrexed Safety Profile
Hazard Codes: 
Xi
Risk Statements:
36/38: Irritating to eyes and skin
The Safety Statements information of Raltitrexed:
37/39: Wear suitable gloves and eye/face protection
Raltitrexed Specification
Raltitrexed , with CAS number of 112887-68-0, can be called L-glutamic acid, N-[[5-[[(1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]- ; L-glutamic acid, N-[[5-[[(3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]- ; N-(5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic acid ; N-[(5-{Methyl[(2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl]amino}-2-thienyl)carbonyl]-L-glutamic acid , it is a yellow crystalline powder. It is a Folate-based inhibitor of thymidylate synthase; rapidly and extensively metabolized to its more potent polyglutamate derivatives.
What can I do for you?
Get Best Price
